Involvement of non‑coding RNAs in the pathogenesis of myocardial ischemia/reperfusion injury (Review)

Qi Li1, Zhuqing Li1, Zhixing Fan2

  • 1School of Medicine, Nankai University, Tianjin 300071, P.R. China.

Insights

Small non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play a crucial role in myocardial ischemia/reperfusion injury (MIRI). Understanding their function offers new insights into treating heart conditions.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Genetics

Background:

  • Myocardial ischemia/reperfusion injury (MIRI) significantly impacts patient prognosis after cardiac interventions.
  • Pathogenesis of MIRI involves apoptosis, inflammation, oxidative stress, calcium overload, and autophagy.
  • Small non-coding RNAs (ncRNAs) are emerging regulators of cellular processes.

Purpose of the Study:

  • To review the characteristics and biological roles of ncRNAs.
  • To emphasize the specific involvement of ncRNAs in MIRI.
  • To highlight the complexity of ischemic heart mechanisms.

Main Methods:

  • Review of recent advancements in RNA sequencing and genome-wide analyses.
  • Analysis of literature on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs).
  • Focus on the regulatory functions of ncRNAs at transcriptional, post-transcriptional, and epigenetic levels.

Main Results:

  • ncRNAs modulate critical cellular processes including signal transduction and gene expression.
  • Dysregulation of miRNAs, lncRNAs, and circRNAs is implicated in MIRI pathogenesis.
  • ncRNAs offer novel insights into the molecular mechanisms underlying MIRI.

Conclusions:

  • ncRNAs represent a complex regulatory network in the ischemic heart.
  • Understanding ncRNA roles in MIRI provides potential therapeutic targets.
  • Further research into ncRNAs can advance MIRI treatment strategies.